PCM
ZYNE

Prentice Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Prentice Capital Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-390,381
Closed -$1.29M – 35
2020
Q3 		$1.29M Sell
390,381
-38,495
-9% -$127K 0.49% 15
2020
Q2 		$1.45M Buy
428,876
+87,440
+26% +$295K 0.53% 16
2020
Q1 		$1.31M Buy
341,436
+131,820
+63% +$505K 0.62% 25
2019
Q4 		$1.27M Buy
+209,616
New +$1.27M 0.6% 17